Time Domian Electron Paramagnetic Resonance Imaging

时域电子顺磁共振成像

基本信息

项目摘要

a) Evaluation of TH-302 as an in vivo radiation sensitizer. TH-302 is a hypoxia activated prodrug which has a nitroimidazole trigger linked to a nitrogen mustard covalntly. Upon redox-activation of the nitroimidazole moiety, in hypoxic conditions, TH-302 fragments and releases the nitrogen mustard moiety exerting significant hypoxia specific cytotoxicity. Since the nitroimidazole moiety can itself act as a radiosensitizer, we examined the combined effect of TH-302 and radiation in vitro and in vivo. We used the two tumor models: The SCCVII tumor and the HT29 tumor in mice. In vitro studies show that incubation of these cells with TH-302 at 10 M level results in radiosensitzation similar to the well-known radiosensitizer, misonidazole. In vivo studies show that, the combined TH-302 + 3 Gy radiation resulted in a significant tumor growth delay compared to ether TH-302 alone or radiation alone. These results suggest the benefits of combination chemoradiation therapy with TH-302. b) Mechanistic studies of the mode of action of the anti-tumor agent CG-0321: CG-0321 is a sulfoglycolipid which has been shown to sensitize tumors to ionizing radiation. However the mechanistic details are not clearly established with some studies pointing to transient increases in tumor oxygenation after drug administration. In vitro studies show no evidence of radiosensitization in several cell lines tested. In vivo imaging studies show that there is a time window of increased tumor pO2 30 - 60 mins after CG-0321 administration. The magnitude increase in tumor pO2 was tumor type dependent. Additional imaging studies show that there is increased tumor perfusion after drug administration. In vivo tumor growth kinetics studies monitoring treatment response in SCCVII and A549 cells show that there is a significant growth delay when radiation treatment was administered at about 30 mins after CG-0321 administration. These studies show the value of molecular imaging techniques probing the tumor microenvironment in understanding the mechanistic aspects of drug action and also the use of such imaging modalities to plan treatments.
A)评价TH-302作为体内辐射增敏剂的作用。TH-302是一种低氧激活的前药,它有一个与氮芥末相连的硝基咪唑触发器。当硝基咪唑部分氧化还原激活时,在低氧条件下,TH-302裂解并释放具有显著的低氧特异性细胞毒性的氮芥酸部分。由于硝基咪唑部分本身可以作为放射增敏剂,我们在体外和体内考察了TH-302和辐射的联合作用。我们使用了两种肿瘤模型:SCCVII肿瘤和HT29肿瘤。体外研究表明,将这些细胞与10M水平的TH-302孵育,可产生类似于众所周知的放射增敏剂咪唑硝唑的放射增敏作用。体内研究表明,与TH-302单独或单独照射相比,TH-302+3Gy射线联合照射导致肿瘤生长明显延迟。这些结果提示放化疗与TH-302联合治疗的益处。B)抗肿瘤药物CG-0321作用模式的机理研究:CG-0321是一种磺基糖脂,已被证明能使肿瘤对电离辐射敏感。然而,机制细节尚不清楚,一些研究指出,给药后肿瘤氧合一过性增加。体外研究表明,在几个被测试的细胞系中没有放射增敏的证据。活体成像研究表明,在给予CG-0321后30-60分钟,肿瘤的PO2有一个上升的时间窗口。肿瘤氧分压的增加幅度与肿瘤类型有关。更多的影像研究表明,给药后肿瘤的血流灌注增加。体内肿瘤生长动力学研究监测治疗反应的SCCVII和A549细胞显示,放射治疗后约30min给予CG-0321有明显的生长延迟。这些研究表明,分子成像技术探测肿瘤微环境在了解药物作用的机制方面以及使用此类成像方式来计划治疗方面具有价值。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

murali cherukuri其他文献

murali cherukuri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('murali cherukuri', 18)}}的其他基金

Continuous Wave Electron Paramagnetic Resonance Imaging
连续波电子顺磁共振成像
  • 批准号:
    8349015
  • 财政年份:
  • 资助金额:
    $ 109.12万
  • 项目类别:
Overhauser Enhanced Magnetic Resonance Imaging (OMRI)
奥豪瑟增强磁共振成像 (OMRI)
  • 批准号:
    10926023
  • 财政年份:
  • 资助金额:
    $ 109.12万
  • 项目类别:
Continuous Wave Electron Paramagnetic Resonance Imaging
连续波电子顺磁共振成像
  • 批准号:
    7592719
  • 财政年份:
  • 资助金额:
    $ 109.12万
  • 项目类别:
Time Domian Electron Paramagnetic Resonance Imaging
时域电子顺磁共振成像
  • 批准号:
    8552702
  • 财政年份:
  • 资助金额:
    $ 109.12万
  • 项目类别:
Continuous Wave Electron Paramagnetic Resonance Imaging
连续波电子顺磁共振成像
  • 批准号:
    7338601
  • 财政年份:
  • 资助金额:
    $ 109.12万
  • 项目类别:
Overhauser Enhanced Magnetic Resonance Imaging (OMRI)
奥豪瑟增强磁共振成像 (OMRI)
  • 批准号:
    8349014
  • 财政年份:
  • 资助金额:
    $ 109.12万
  • 项目类别:
Time Domian Electron Paramagnetic Resonance Imaging
时域电子顺磁共振成像
  • 批准号:
    8175326
  • 财政年份:
  • 资助金额:
    $ 109.12万
  • 项目类别:
Overhauser Enhanced Magnetic Resonance Imaging (OMRI)
奥豪瑟增强磁共振成像 (OMRI)
  • 批准号:
    7965338
  • 财政年份:
  • 资助金额:
    $ 109.12万
  • 项目类别:
Time Domian Electron Paramagnetic Resonance Imaging
时域电子顺磁共振成像
  • 批准号:
    7292182
  • 财政年份:
  • 资助金额:
    $ 109.12万
  • 项目类别:
Overhauser Enhanced Magnetic Resonance Imaging (OMRI)
奥豪瑟增强磁共振成像 (OMRI)
  • 批准号:
    7292183
  • 财政年份:
  • 资助金额:
    $ 109.12万
  • 项目类别:

相似海外基金

DMS-EPSRC: Asymptotic Analysis of Online Training Algorithms in Machine Learning: Recurrent, Graphical, and Deep Neural Networks
DMS-EPSRC:机器学习中在线训练算法的渐近分析:循环、图形和深度神经网络
  • 批准号:
    EP/Y029089/1
  • 财政年份:
    2024
  • 资助金额:
    $ 109.12万
  • 项目类别:
    Research Grant
CAREER: Blessing of Nonconvexity in Machine Learning - Landscape Analysis and Efficient Algorithms
职业:机器学习中非凸性的祝福 - 景观分析和高效算法
  • 批准号:
    2337776
  • 财政年份:
    2024
  • 资助金额:
    $ 109.12万
  • 项目类别:
    Continuing Grant
CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
  • 批准号:
    2338816
  • 财政年份:
    2024
  • 资助金额:
    $ 109.12万
  • 项目类别:
    Continuing Grant
CAREER: Structured Minimax Optimization: Theory, Algorithms, and Applications in Robust Learning
职业:结构化极小极大优化:稳健学习中的理论、算法和应用
  • 批准号:
    2338846
  • 财政年份:
    2024
  • 资助金额:
    $ 109.12万
  • 项目类别:
    Continuing Grant
CRII: SaTC: Reliable Hardware Architectures Against Side-Channel Attacks for Post-Quantum Cryptographic Algorithms
CRII:SaTC:针对后量子密码算法的侧通道攻击的可靠硬件架构
  • 批准号:
    2348261
  • 财政年份:
    2024
  • 资助金额:
    $ 109.12万
  • 项目类别:
    Standard Grant
CRII: AF: The Impact of Knowledge on the Performance of Distributed Algorithms
CRII:AF:知识对分布式算法性能的影响
  • 批准号:
    2348346
  • 财政年份:
    2024
  • 资助金额:
    $ 109.12万
  • 项目类别:
    Standard Grant
CRII: CSR: From Bloom Filters to Noise Reduction Streaming Algorithms
CRII:CSR:从布隆过滤器到降噪流算法
  • 批准号:
    2348457
  • 财政年份:
    2024
  • 资助金额:
    $ 109.12万
  • 项目类别:
    Standard Grant
EAGER: Search-Accelerated Markov Chain Monte Carlo Algorithms for Bayesian Neural Networks and Trillion-Dimensional Problems
EAGER:贝叶斯神经网络和万亿维问题的搜索加速马尔可夫链蒙特卡罗算法
  • 批准号:
    2404989
  • 财政年份:
    2024
  • 资助金额:
    $ 109.12万
  • 项目类别:
    Standard Grant
CAREER: Efficient Algorithms for Modern Computer Architecture
职业:现代计算机架构的高效算法
  • 批准号:
    2339310
  • 财政年份:
    2024
  • 资助金额:
    $ 109.12万
  • 项目类别:
    Continuing Grant
CAREER: Improving Real-world Performance of AI Biosignal Algorithms
职业:提高人工智能生物信号算法的实际性能
  • 批准号:
    2339669
  • 财政年份:
    2024
  • 资助金额:
    $ 109.12万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了